IMDX
Insight Molecular Diagnostics Inc.NASDAQHEALTHCAREDIAGNOSTICS & RESEARCH
Key Statistics
Market Cap
$196.65M
P/E Ratio
—
EPS
$-1.51
Beta
1.63
52W High
$8.51
52W Low
$2.33
50-Day MA
$4.28
200-Day MA
$4.92
Dividend Yield
—
Profit Margin
0.00%
Forward P/E
—
PEG Ratio
—
About Insight Molecular Diagnostics Inc.
OncoCyte Corporation is a precision diagnostics company in the United States and internationally. The company is headquartered in Irvine, California.
Fundamentals
| Revenue (TTM) | $1.95M |
| Gross Profit (TTM) | 995,000 |
| EBITDA | $-32.57M |
| Operating Margin | -32284.00% |
| Return on Equity | -23603.00% |
| Return on Assets | -43.30% |
| Revenue/Share (TTM) | $0.06 |
| Book Value | $-1.10 |
| Price-to-Book | 87.06 |
| Price-to-Sales (TTM) | 100.90 |
| EV/Revenue | 88.0 |
| EV/EBITDA | -1.25 |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | -98.50% |
| Shares Outstanding | $32.29M |
| Float | $10.08M |
| % Insiders | 20.02% |
| % Institutions | 61.45% |
Historical Volatility
HV 10-Day
152.89%
HV 20-Day
151.65%
HV 30-Day
145.47%
HV 60-Day
156.41%
HV Rank
87.7%
Volatility is currently expanding
Analyst Ratings
Consensus ($8.33 target)
1
Strong Buy1
Buy2
HoldMore HEALTHCARE Stocks
Data last updated: 5/25/2026